Variability of MRI Aortic Stiffness Measurements in a Multicenter Clinical Trial Setting: Intraobserver, Interobserver, and Intracenter Variability of Pulse Wave Velocity and Aortic Strain Measurement
Maja Hrabak-Paar, Achim Kircher, Saeed Al Sayari, Sebastien Kopp, Francesco Santini, Roland E Schmieder, Nadjia Kachenoura, Denise Yates, Thomas Langenickel, Jens Bremerich, Tobias Heye, Maja Hrabak-Paar, Achim Kircher, Saeed Al Sayari, Sebastien Kopp, Francesco Santini, Roland E Schmieder, Nadjia Kachenoura, Denise Yates, Thomas Langenickel, Jens Bremerich, Tobias Heye
Abstract
Purpose: To assess intraobserver, interobserver, and scan-rescan variability of MRI aortic stiffness measurements in a multicenter trial setting.
Materials and methods: This study was a retrospective analysis of prospectively collected data in a multicenter prospective clinical trial (clinicaltrials.gov ID NCT01870739). Forty-five adult patients (31 men; mean age, 58 years ± 12 [standard deviation]; 15 patients per center; three centers) with arterial hypertension underwent standardized 3-T baseline MRI assessments between June and September 2014. Aortic strain was calculated from maximum and minimum aortic area measurements repeated three times by three readers at three aortic levels on three retrospectively gated axial gradient-echo (GRE) data sets. Pulse wave velocity (PWV) was assessed three times by five readers as Δx/Δt: Δx was measured on a parasagittal GRE image of the aortic arch, and Δt was extracted from ascending and descending aortic velocity curves created on three axial phase-contrast acquisitions. Intraobserver, interobserver, and scan-rescan variability was calculated using percentage coefficient of variation (COV).
Results: Aortic strain variability was lowest at the level of the distal descending aorta (DDA) with median COVs of 1.6% for intraobserver variability, 4.0% for interobserver variability, and 10.3% for scan-rescan variability. It was highest at the ascending aorta (AA) with COVs of 3.6% for intraobserver variability, 10.7% for interobserver variability, and 19.8% for scan-rescan variability. Variability of PWV was low: 0.7% for intraobserver variability, 1.5% for interobserver variability, and 8.1% for scan-rescan variability.
Conclusion: Low variability can be achieved for aortic strain and PWV measurements in a multicenter trial setting using standardized MRI protocols. Although COV was lower when measuring aortic strain at DDA compared with AA, variability was acceptable at both anatomic locations.Supplemental material is available for this article.© RSNA, 2020.
Conflict of interest statement
Disclosures of Conflicts of Interest: M.H.P. disclosed no relevant relationships. A.K. disclosed no relevant relationships. S.A.S. disclosed no relevant relationships. S.K. disclosed no relevant relationships. F.S. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: employed by University Hospital Basel; institution receives grants from Swiss National Science Foundation and Swiss Foundation for the Research on Muscle Diseases; author receives travel accommodations from ESMRMB. Other relationships: disclosed no relevant relationships. R.E.S. disclosed no relevant relationships. N.K. disclosed no relevant relationships. D.Y. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: employed by Novartis Institutes of Biomedical Research which sponsored the clinical trial during which the aortic MRI data were acquired. Other relationships: disclosed no relevant relationships. T.L. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: employed by and has stock in Novartis Pharma. Other relationships: disclosed no relevant relationships. J.B. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: disclosed no relevant relationships. Other relationships: University Hospital Basel was involved in a trial from Novartis and received funds for performing and analyzing MRI scans. The current analysis and manuscript, however, was done after the analysis for Novartis was completed. The current study used the image database, but otherwise is not related to the Novartis trial. T.H. disclosed no relevant relationships.
2020 by the Radiological Society of North America, Inc.
Figures
Source: PubMed